AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company, founded in 1999 with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. AstraZeneca is one of the largest pharmaceutical companies in the world, with a portfolio of products in oncology, cardiovascular, gastrointestinal, infection, neuroscience, etc. It was also involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
According to reports, AstraZeneca has announced plans to build a $1.5 billion USD manufacturing facility in Singapore to produce antibody-drug conjugates (ADCs). The facility is expected to be completed in 2029 and will be the first end-to-end ADC production site and aims for zero carbon emissions from the start of operations.
ADCs are next-generation treatments that target cancer cells by delivering highly potent cancer-killing agents through a targeted antibody.
